| Literature DB >> 32376865 |
Jennifer I Lissemore1, Atsuko Nagano-Saito2, Kelly Smart2, Paul Gravel2,3, Marco Leyton2,3, Chawki Benkelfat2,3.
Abstract
When a cue no longer predicts a threat, a diminished ability to extinguish or reverse this association is thought to increase risk for stress-related disorders. Despite the clear clinical relevance, the mediating neurochemical mechanisms of threat reversal have received relatively little study. One neurotransmitter implicated in rodent research of changing associations with threat is dopamine. To study whether dopamine is involved in threat reversal in humans, we used high-resolution positron emission tomography (PET) coupled with 18F-fallypride. Twelve healthy volunteers (6 F/6 M) underwent three PET scans: (i) at baseline, (ii) following threat conditioning (the response to a cue associated with electric wrist shock), and (iii) following threat reversal (the response to the same cue now associated with safety). We observed moderate evidence of reduced dopamine D2/3 receptor availability, consistent with greater dopamine release, in the bilateral anterior hippocampus following threat reversal, in response to a safety cue that was previously associated with threat, as compared to both baseline and during exposure to the same cue prior to threat reversal. These findings offer the first preliminary evidence that the response to a previously threatening cue that has since become associated with safety involves dopaminergic neurotransmission within the hippocampus in healthy humans.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32376865 PMCID: PMC7203150 DOI: 10.1038/s41598-020-63977-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Study timeline. Timeline of the three PET scans and two stimulus pairing sessions.
Figure 2Autonomic evidence of conditioned responses to threat. (a) Percentage frequency of skin conductance responses (SCRs) in the first 10 trials of each PET scan. (b) An example from one participant of SCRs over time during PET2CS+ (in response to a cue associated with threat). Each trial was 30 s: the triangle indicates the onset of the 3 s conditioned stimulus, which was followed by a 20 s countdown, and a blank screen during which the participant expected to receive an aversive shock.
Descriptive and linear mixed model statistics for 18F-fallypride BPND across PET sessions. Mean ± SD BPND shown. VTA = ventral tegmental area, vmPFC = ventromedial prefrontal cortex.
| Region of Interest (bilateral) | Non-Displaceable Binding Potential (BPND) | Linear Mixed Model Statistics | |||
|---|---|---|---|---|---|
| Baseline (PETBL) | Response to threat cue (PET2CS+) | Response to safety cue (PET3CS−) | Main effect of session | Session × hemisphere interaction | |
| Hippocampus | 2.17 ± 0.56 | 2.14 ± 0.46 | 1.98 ± 0.36 | F2,55 = 3.5 | F2,55 = 0.01 |
| Amygdala | 3.62 ± 1.11 | 3.44 ± 0.69 | 3.25 ± 0.64 | F2,55 = 2.9 | F2,55 = 0.05 |
| vmPFC | 0.49 ± 0.12 | 0.53 ± 0.12 | 0.49 ± 0.14 | F2,55 = 2.0 | F2,55 = 0.4 |
| Nucleus Accumbens | 18.61 ± 4.09 | 18.29 ± 2.65 | 17.54 ± 3.05 | F2,55 = 2.5 | F2,55 = 0.003 |
| VTA | 2.11 ± 0.35 | 2.07 ± 0.31 | 2.06 ± 0.31 | F2,22 = 0.3 | — |
Figure 3Dopamine receptor binding across PET sessions in the hippocampus (HPC) and ventromedial prefrontal cortex (vmPFC). Mean non-displaceable binding potential (BPND) values are significantly lower in bilateral anterior hippocampus (HPC), but not in the vmPFC, in response to the updated safety cue following threat reversal (PET3CS−), as compared to baseline (PETBL) and in response to the same cue prior to threat reversal (PET2CS+). The observed decrease in BPND between scans is consistent with an increase in dopamine release. Error bars represent 95% confidence intervals.
Bayesian repeated measures ANOVA statistics. Bayes factors with percentage error for main effect and interaction models, and post hoc comparisons. All models are compared to the null model including hemisphere as a nuisance variable (H0; no effect). The posterior odds were corrected for multiple comparisons in the post hoc comparisons. Bayes factors >3 are bolded to indicate evidence for an effect (in favour of H1).
| Region of Interest | Bayesian Statistics: Bayes Factor [error] | Post Hoc Comparisons: Bayes Factor [error] | |||
|---|---|---|---|---|---|
| PET Session | PET Session + PET Session*Hemisphere | PETBL vs. PET2CS+ | PETBL vs. PET3CS− | PET2CS+ vs. PET3CS− | |
| Hippocampus | 1.72 [2.6%] | 0.32 [2.4%] | 0.26 [0.04%] | ||
| Amygdala | 1.11 [2.4%] | 0.23 [2.7%] | 0.33 [0.04%] | 1.50 [0.007%] | |
| vmPFC | 0.55 [1.6%] | 0.14 [2.9%] | 0.63 [0.0001%] | 0.22 [0.03%] | 0.71 [0.0001%] |
| Nucleus Accumbens | 0.81 [2.0%] | 0.16 [5.4%] | 0.26 [0.04%] | 1.75 [0.005%] | 1.44 [0.008%] |
| VTA | 0.23 [0.7%] | — | 0.32 [0.02%] | 0.40 [0.02%] | 0.29 [0.02%] |
Figure 4Timeline of each PET scan. (a) PETBL with no stimulus presentations. (b) PET2CS+ with 60 presentations of the CS+ (neutral shape associated with shock). (c) PET3CS− with 60 presentations of the new CS− (neutral shape no longer paired with shock).